
Sofinnovarevenue
Venture CapitalMenlo Park, CaliforniaFounded 1976
Sofinnova is a clinical-stage biopharmaceutical venture capital firm, active in life science investing, primarily focusing on therapeutic drugs.
Sofinnova revenue
Sofinnova has not published its revenue. Growjo puts it at about $11.8M a year (September 2025).
$0
$5M
$10M
$0
–
$11.8M
19761977–242025
| As of | Revenue | Source |
|---|---|---|
| Sep 2025 | $11.8MEST | Growjo estimate |
Sofinnova employees
Sofinnova has 58 employees (September 2025, LinkedIn).
0
20
40
58
2025
Sofinnova FAQ
Browse Venture Capital
- October$11.8M
- Crux$11.7M
- EvoNexus$11.6M
- MedStartr$12M
- AI Salon$12.2M
- TIMIA Capital$11.3M
- Pasadena Angels$11.2M
- DEV$11.1M
- Y Combinator$11M
- Covr Financial Technologies$10.8M
- ImPak Finance$10.7M
- FounderFuel$10.5M
- Invictus Growth Partners$10.4M
- Just Climate$13.2M
- Jacobi$13.2M
- Founderpath$13.5M
- RKCA Investment Banking$13.6M
- Furey Financial$10M
- Incubate Fund$10M
- Lighter Capital$9.9M
How this page is sourced
1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun Sofinnova? Join the podcast